Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
Shanghai, Jun 23, 2025 - (ACN Newswire) - Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company